Scholars Central

Research articlePublished 3 May 2019

Synthesis, characterization and antiviral evaluation of some novel 2- [(substitutedphenyl/heteroaryl)imino]-3-phenyl-1,3-thiazolidin-4-ones

Authors: G. Nagalakshmi, T. K. Maity, B. C. Maiti

Der Pharmacia Lettre

Volume 5 · Issue 2 · Pages 177–188

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A series of novel 2-[(substitutedphenyl/heteroaryl)imino]-3-phenyl-1,3-thiazolidin-4-ones (4a-g) were synthesized and structurally confirmed by elemental, IR, 1H NMR and MS spectral analysis. Further, the antiviral screening of 2-[(substitutedphenyl/heteroaryl)imino]-3-phenyl-1,3-thiazolidin-4-ones (4a-g) against a broad panel of DNA and RNA viral strains indicated that (2Z)-3-phenyl-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-one (4c), (2Z)-2-[(2,6- dimethylphenyl)imino]-3-phenyl-1,3-thiazolidin-4-one (4g), (2Z)-2-[(3,4-dimethylphenyl)imino]-3-phenyl-1,3- thiazolidin-4-one (4a) and (2E)-3-phenyl-2-(pyridin-3-ylimino)-1,3-thiazolidin-4-one (4d) showed promising antiviral activity against vesicular stomatitis virus (EC50 = 4, 8, 9 and 11 μM, respectively) tested in HeLa cell culture, (2Z)-2-[(3,4-dimethylphenyl)imino]-3-phenyl-1,3-thiazolidin-4-one (4a) emerged as the best antiviral agent against cytomegalovirus [EC50 = 49 μM (AD-169 and Davis)], (2E)-3-phenyl-2-(pyridin-3-ylimino)-1,3-thiazolidin- 4-one (4d) and (2E)-2-[(3,5-dimethylphenyl)imino]-3-phenyl-1,3-thiazolidin-4-one (4f) against varicella-zoster virus (VZV) [thymidine kinase positive (TK+) VZV (OKA strain)] (EC50 = 39 and 39 μM, respectively). (2Z)-3- phenyl-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-one (4c) was active against varicella-zoster virus (VZV) [thymidine kinase deficient (TK-) VZV (07/1 strain)] (EC50 = 37 μM) tested in human embryonic lung (HEL) cell cultures. They may be considered as potential lead compounds for the development of novel antiviral agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharmacia Lettre
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “G. Nagalakshmi”
  • BylineArticles whose byline prints “T. K. Maity”
  • BylineArticles whose byline prints “B. C. Maiti”